Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy

BACKGROUND: Hepatitis C virus roots a chronic liver disease. Currently approved treatment strategy includes administration of alpha interferon and ribavirin combined therapy for 24-48 weeks. One of the predictor of sustained virological response is an early virological response to treatment characte...

詳細記述

保存先:
書誌詳細
主要な著者: Akram, Madiha, Idrees, Muhammad, Hussain, Abrar, Afzal, Samia, Ilyas, Muhammad, Zafar, Shamail, Aftab, Mahwish, Badar, Sadaf, Khubaib, Bushra
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2011
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117844/
https://ncbi.nlm.nih.gov/pubmed/21605410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-8-253
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料